Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
11
BLGO Quote, Financials, Valuation and Earnings
Last price:
$0.15
Seasonality move
:
-1.28%
Day range:
$0.15 - $0.16
52-week range:
$0.14 - $0.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.89x
P/B ratio:
11.78x
Volume:
688.7K
Avg. volume:
180.6K
1-year change:
-46.55%
Market cap:
$47.6M
Revenue:
$7.8M
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingBioLargo, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $0.32, BioLargo, Inc. has an estimated upside of 114.05% from its current price of $0.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.32 representing -- downside risk from its current price of $0.15.
Fair Value
-
According to the consensus of 1 analyst, BioLargo, Inc. has 114.05% upside to fair value with a price target of $0.32 per share.
BLGO vs. S&P 500
-
Over the past 5 trading days, BioLargo, Inc. has underperformed the S&P 500 by -3.25% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
BioLargo, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BioLargo, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter BioLargo, Inc. reported revenues of $617K.
Earnings Growth
-
BioLargo, Inc. earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter BioLargo, Inc. reported earnings per share of -$0.01.
Enterprise value:
44.9M
EV / Invested capital:
--
Price / LTM sales:
5.89x
EV / EBIT:
--
EV / Revenue:
5.78x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-5.38x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$3.4M
Return On Assets:
-149.02%
Net Income Margin (TTM):
-195.58%
Return On Equity:
-346.04%
Return On Invested Capital:
-197.03%
Operating Margin:
-647.81%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $12.2M | $17.8M | $7.8M | $3.7M | $617K | |
| Gross Profit | $6.2M | $7.9M | $3.4M | $1.8M | $128K | |
| Operating Income | -$4.2M | -$4.3M | -$14.8M | -$1.6M | -$4M | |
| EBITDA | -$3.9M | -$4.1M | -$14.5M | -$1.5M | -$3.9M | |
| Diluted EPS | -$0.01 | -$0.01 | -$0.04 | -$0.00 | -$0.01 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8M | $3.2M | $6.4M | $7.1M | $5.1M | |
| Total Assets | $3M | $4.9M | $8.2M | $10.5M | $8.3M | |
| Current Liabilities | $1.4M | $1.6M | $2.7M | $2.6M | $5.1M | |
| Total Liabilities | $2.1M | $2.8M | $4M | $4.5M | $6.8M | |
| Total Equity | $933K | $2M | $4.2M | $6.1M | $1.5M | |
| Total Debt | $1M | $1.4M | $1.4M | $2.4M | $3.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.4M | -$3.2M | -$8.3M | -$1.9M | -$1.6M | |
| Cash From Investing | -$478K | -$1.3M | $435K | -$57K | -$13K | |
| Cash From Financing | $4.7M | $4.4M | $8.2M | $1.6M | $952K | |
| Free Cash Flow | -$2.8M | -$4.4M | -$8.3M | -$1.9M | -$1.6M | |
BLGO
Sector
Market Cap
$47.6M
$23.6M
Price % of 52-Week High
--
62.93%
Dividend Yield
0%
0%
Shareholder Yield
-12.57%
-3.93%
1-Year Price Total Return
-46.55%
14.68%
Beta (5-Year)
-0.109
0.610
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.16
200-day SMA
Sell
Level
$0.18
Bollinger Bands (100)
Sell
Level
0.17 - 0.19
Chaikin Money Flow
Sell
Level
-447.6K
20-day SMA
Sell
Level
$0.16
Relative Strength Index (RSI14)
Sell
Level
28.90
ADX Line
Sell
Level
43.14
Williams %R
Buy
Level
-91.6537
50-day SMA
Sell
Level
$0.17
MACD (12, 26)
Buy
Level
0.03
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Sell
Level
-1.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-26.9465)
Sell
CA Score
(Annual)
Level (-6.4005)
Buy
Beneish M-Score
(Annual)
Level (-5.8526)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (12.0472)
Sell
Piotroski F Score
(Annual)
Level (2)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. It operates through the following segments: ONM Environmental, BLEST, BioLargo Water, Clyra Medical and Corporate Operations. The ONM Environmental segment manufactures and sells odor and VOC control products and services, including its flagship product, CupriDyne Clean. The BLEST segment offers professional engineering services through its internal business units. The BioLargo Water is a Canadian division which focuses on commercializing AOS systems. The Clyra Medical segment focuses on the advanced wound care industry. The Corporate Operations segment supports the operating segments with legal, accounting, human resources, and other related services. The company was founded on September 19, 1991 and is headquartered in Westminster, CA.
Stock Forecast FAQ
In the current month, BLGO has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BLGO average analyst price target in the past 3 months is $0.32.
-
Where Will BioLargo, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that BioLargo, Inc. share price will rise to $0.32 per share over the next 12 months.
-
What Do Analysts Say About BioLargo, Inc.?
Analysts are divided on their view about BioLargo, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BioLargo, Inc. is a Sell and believe this share price will drop from its current level to $0.32.
-
What Is BioLargo, Inc.'s Price Target?
The price target for BioLargo, Inc. over the next 1-year time period is forecast to be $0.32 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BLGO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BioLargo, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of BLGO?
You can purchase shares of BioLargo, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BioLargo, Inc. shares.
-
What Is The BioLargo, Inc. Share Price Today?
BioLargo, Inc. was last trading at $0.15 per share. This represents the most recent stock quote for BioLargo, Inc.. Yesterday, BioLargo, Inc. closed at $0.15 per share.
-
How To Buy BioLargo, Inc. Stock Online?
In order to purchase BioLargo, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BLGO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BLGO
Sector
P/E ratio
--
18.27x
PEG ratio
-0.01x
-0.03x
P/B ratio
11.78x
1.74x
Price / LTM sales
5.89x
1.53x
Growth Metrics
BLGO
Sector
Revenue growth
-83.13%
3.23%
Earnings growth
-176.47%
--
Revenue (5-year growth)
26.14%
4.13%
Earnings forecast
-$0.01
$0.02
Profitability
BLGO
Sector
Profitability FY 2025
$3.4M
--
Return on invested capital
-197.03%
-10.8%
Return on assets
-149.02%
-12.47%
Return on equity
-346.04%
-11.36%
Earnings Date
Last Earnings Date
Apr
5
Next Earnings Date
Apr
5
Estimated Next Earnings Date
Jul
5
Balance Sheet
BLGO
Sector
Total cash
$3.9M
$2.6M
Short term investments
--
$199.8K
Total assets
$8.3M
$16.4M
Long term debt
$3.3M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 5
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
